Skip to main content
. 2017 Dec 21;70(6):463–467. doi: 10.4212/cjhp.v70i6.1714

Table 1.

Anti-Xa Levels and Apixaban Concentrations for a Patient Who Also Received Carbamazepine

Level or Concentration

Variable While Taking Carbamazepine While Not Taking Carbamazepine Test Method or Calculation
Trough
Heparin level, local testing 0.84 U/mL (13:23 h since last apixaban dose) 0.63 U/mL (13:18 h since last apixaban dose) Biophen heparin 6 assay
Apixaban concentration, local calculation 62 ng/mL 45 ng/mL Apixaban = (heparin – 0.0482)/0.0128
Apixaban concentration, Hamilton laboratory 64 ng/mL 46 ng/mL STA-Liquid Anti-Xa assay calibrated with STA-Apixaban Calibrator (reference range 22–230 ng/mL)

Peak
Heparin level, local testing 1.47 U/mL (2:29 h after apixaban dose) 1.27 U/mL (2:23 h after apixaban dose) Biophen heparin 6 assay
Apixaban concentration, local calculation 111 ng/mL 95 ng/mL Apixaban = (heparin – 0.0482)/0.0128
Apixaban concentration, Hamilton laboratory 110 ng/mL 92 ng/mL STA-Liquid Anti-Xa assay calibrated with STA-Apixaban calibrator (reference range 59–321 ng/mL)